In vitro Evaluation of Novel Sustained Release Microspheres of Glipizide Prepared by the Emulsion Solvent Diffusion-Evaporation Method
2010

Sustained Release Microspheres of Glipizide

publication Evidence: moderate

Author Information

Author(s): Prasanna Phutane, Shidhaye S, Lotlikar V, Ghule A, Sutar S, Kadam V

Primary Institution: Bharati Vidyapeeth’s College of Pharmacy

Hypothesis

The objective of the current investigation is to reduce dosing frequency and improve patient compliance by designing and systematically evaluating sustained release microspheres of Glipizide.

Conclusion

The study successfully developed a sustained release formulation of Glipizide microspheres that can release the drug over approximately 12 hours, enhancing patient compliance.

Supporting Evidence

  • The microspheres showed good flow properties and were spherical with smooth surfaces.
  • Batch F3 had the highest drug encapsulation efficiency and sustained release for about 12 hours.
  • The formulation was less complex and used cost-effective, biocompatible polymers.

Takeaway

Scientists made tiny balls that slowly release a diabetes medicine called Glipizide, so people don't have to take it as often.

Methodology

The microspheres were created using the emulsion solvent diffusion-evaporation method with ethyl cellulose and Eudragit® S100 as polymers.

Limitations

The study does not address the long-term effects of the sustained release microspheres in human subjects.

Digital Object Identifier (DOI)

10.4103/0975-1483.62210

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication